- Home
- BTMD vs COYA Comparison
BTMD vs COYA Comparison
Compare BTMD & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- COYA
- Stock Information
- Founded
- BTMD 2012
- COYA 2020
- Country
- BTMD United States
- COYA United States
- Employees
- BTMD N/A
- COYA N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- BTMD Health Care
- COYA Health Care
- Exchange
- BTMD Nasdaq
- COYA Nasdaq
- Market Cap
- BTMD 104.2M
- COYA 92.2M
- IPO Year
- BTMD N/A
- COYA 2022
- Fundamental
- Price
- BTMD $3.43
- COYA $6.18
- Analyst Decision
- BTMD Strong Buy
- COYA Strong Buy
- Analyst Count
- BTMD 1
- COYA 4
- Target Price
- BTMD $8.00
- COYA $17.00
- AVG Volume (30 Days)
- BTMD 151.0K
- COYA 85.1K
- Earning Date
- BTMD 05-07-2025
- COYA 05-08-2025
- Dividend Yield
- BTMD N/A
- COYA N/A
- EPS Growth
- BTMD N/A
- COYA N/A
- EPS
- BTMD 0.09
- COYA N/A
- Revenue
- BTMD $197,191,000.00
- COYA $3,554,061.00
- Revenue This Year
- BTMD $6.20
- COYA $94.45
- Revenue Next Year
- BTMD $9.24
- COYA N/A
- P/E Ratio
- BTMD $38.33
- COYA N/A
- Revenue Growth
- BTMD 6.38
- COYA N/A
- 52 Week Low
- BTMD $3.04
- COYA $4.65
- 52 Week High
- BTMD $8.44
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- BTMD 44.75
- COYA 52.54
- Support Level
- BTMD $3.25
- COYA $5.06
- Resistance Level
- BTMD $3.63
- COYA $7.05
- Average True Range (ATR)
- BTMD 0.23
- COYA 0.65
- MACD
- BTMD 0.04
- COYA 0.14
- Stochastic Oscillator
- BTMD 48.79
- COYA 63.75
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.